保元活血颗粒治疗老年2型糖尿病气虚血瘀证30例临床观察

目的:探讨中药保元活血颗粒对老年2型糖尿病气虚血瘀证的作用及对血小板颗粒膜糖蛋白p-选择素(CD62p)、纤维蛋白原受体(PAC-1)表达率的影响.方法:选择气虚血瘀证的老年2型糖尿病患者60例,随机分为两组,单纯西药对照组30例,进行常规基础治疗,试验组30例,在常规降糖西药治疗的基础上加用保元活血颗粒,共治疗2个月,观察两组患者临床疗效及治疗前后CD62p、PAC-1表达率的变化.结果:试验组显效12例(40%),有效15例(50%),无效3例(10%),总有效率90%;对照组显效3例(10%),有效12例(40%),无效15例(50%),总有效率为50%;两组总有效率比较差异有显著性(P＜0.01),试验组CD62p、PAC-1表达率较治疗前明显下降(P＜0.05).结论:保元活血颗粒能改善糖尿病患者的气虚血瘀证候,并能降低CD62p、PAC-1的表达率.

Clinical Observation on 30 Cases of Senile Type 2 Diabetes with Qi-Deficiency and Blood Stasis Treated with Baoyuan Huoxue Granule

Objective:To explore effects of Baoyuan Huoxue Granule on senile type 2 diabetes with Qi deficiency and blood stasis,and expression rates of membrane glucoprotein selectin P(CD62p)and fibrin receptor(PAC-1)in the granule of platelet.Methods:60 cases of senile type 2 diabetes with Qi-deficiency and blood stasis were randomly divided into two groups,a simple western medicine control group(n=30)and a test group(n=30)treated by routine western medicine and Baoyuan Huoxue Granule.The treatment was given 2 months.Their clinical therapeutic effects,and the expression rates of CD62p and PAC-1 before and after treatment were investigated.Results:In the test group,12 cases(40%)were markedly effective,15 cases(50%)effective,3 cases (10%)ineffective,with an effective rate of 90%;In the control group,3 cases(10%)were markedly effective,12(40%) effective,15(50%)ineffective.the effective rate being 50%,with significant difference between the two groups in total effective rate(P<0.01).The expression rates of CD62p and PAC-1 in the test group after treatment decreased significantly(P<0.01). Conclusion:Baoyuan Huoxue Granule can improve syndromes of Qi-deficiency and blood stasis,and reduce the expression rates of CD62p and PAC-1 in the diabetic patient.